156 related articles for article (PubMed ID: 2527052)
1. Regression of oral Kaposi's sarcoma in a case of AIDS on zidovudine (AZT).
Langford A; Ruf B; Kunze R; Pohle HD; Reichart P
Br J Dermatol; 1989 May; 120(5):709-13. PubMed ID: 2527052
[TBL] [Abstract][Full Text] [Related]
2. Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma.
de Wit R; Reiss P; Bakker PJ; Lange JM; Danner SA; Veenhof KH
AIDS; 1989 Dec; 3(12):847-50. PubMed ID: 2576629
[TBL] [Abstract][Full Text] [Related]
3. Regression of human immunodeficiency virus-associated oral Kaposi sarcoma with combined antiretroviral therapy: A case report and literature review.
Franco JB; Maureira Pena LJ; Martins E Martins F; de Oliveira MA; Ortega KL
Head Neck; 2019 Feb; 41(2):E21-E25. PubMed ID: 30552825
[TBL] [Abstract][Full Text] [Related]
4. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.
Fahey JL; Prince H; Weaver M; Groopman J; Visscher B; Schwartz K; Detels R
Am J Med; 1984 Jan; 76(1):95-100. PubMed ID: 6229182
[TBL] [Abstract][Full Text] [Related]
5. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
Opravil M; Hirschel B; Bucher HC; Lüthy R
Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
Safai B; Sarngadharan MG; Koziner B; Godbold J; Myskowski PL; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
Cancer Res; 1985 Sep; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700
[TBL] [Abstract][Full Text] [Related]
8. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
[TBL] [Abstract][Full Text] [Related]
9. Regression of Kaposi's sarcoma and improvement of performance status by a combined interferon beta and zidovudine therapy in AIDS patients.
Brockmeyer NH; Mertins L; Daecke C; Goos M
J Invest Dermatol; 1989 May; 92(5):776. PubMed ID: 2715648
[No Abstract] [Full Text] [Related]
10. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
11. Non-pigmented oral kaposi's sarcoma (AIDS). Report of two cases.
Reichart PA; Schiødt M
Int J Oral Maxillofac Surg; 1989 Aug; 18(4):197-9. PubMed ID: 2507665
[TBL] [Abstract][Full Text] [Related]
12. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS).
Tabata M; Langford A; Becker J; Reichart PA
Eur J Cancer B Oral Oncol; 1993 Jul; 29B(3):209-13. PubMed ID: 7905311
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
14. Progressive changes of Kaposi's sarcoma of the gingiva and palate. Case report in an AIDS patient.
Petit JC; Ripamonti U; Hille J
J Periodontol; 1986 Mar; 57(3):159-63. PubMed ID: 3457139
[TBL] [Abstract][Full Text] [Related]
15. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
Dupuy J; Price M; Lynch G; Bruce S; Schwartz M
J Am Acad Dermatol; 1993 Jun; 28(6):966-72. PubMed ID: 8496462
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
17. Tumor infiltrates in acquired immunodeficiency syndrome patients with Kaposi's sarcoma.
Cochran AJ; Nestor MS; Groopman JE; Ahmed AR
Lancet; 1983 Feb; 1(8321):416. PubMed ID: 6130406
[No Abstract] [Full Text] [Related]
18. [Kaposi sarcoma within the scope of AIDS].
Meigel W; Kern P; Dietrich M
Z Hautkr; 1986 May; 61(9):626-8, 633-4. PubMed ID: 3012897
[TBL] [Abstract][Full Text] [Related]
19. T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS.
Spornraft P; Fröschl M; Ring J; Meurer M; Goebel FD; Ziegler-Heitbrock HW; Riethmüller G; Braun-Falco O
Br J Dermatol; 1988 Jul; 119(1):1-9. PubMed ID: 3261596
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group.
Jacobson LP; Muñoz A; Fox R; Phair JP; Dudley J; Obrams GI; Kingsley LA; Polk BF
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S24-31. PubMed ID: 2395082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
